Hoffmann-La Roche
['A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma', '2017-07-05', 'Hoffmann-La Roche', 'multicenter trial']